Welcome to LookChem.com Sign In|Join Free

CAS

  • or

456527-46-1

Post Buying Request

456527-46-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

456527-46-1 Usage

General Description

"Tert-butyl (S)-(3-amino-4-(benzylamino)-4-oxobutyl)carbamate" is a chemical compound with the molecular formula C16H25N3O3. It is a carbamate derivative and has a tert-butyl group attached to the nitrogen atom. The compound contains an amino group, a benzylamino group, and a carbonyl group, making it potentially useful in medicinal chemistry and drug development. It may have applications in the synthesis of pharmaceuticals and as a building block for more complex organic molecules due to its unique structural features. Further research and exploration are needed to fully understand the potential uses and properties of this chemical.

Check Digit Verification of cas no

The CAS Registry Mumber 456527-46-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,5,6,5,2 and 7 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 456527-46:
(8*4)+(7*5)+(6*6)+(5*5)+(4*2)+(3*7)+(2*4)+(1*6)=171
171 % 10 = 1
So 456527-46-1 is a valid CAS Registry Number.

456527-46-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-2-amino-4-(N-Boc-amino)-N'-benzylbutyramide

1.2 Other means of identification

Product number -
Other names (S)-2-amino-4-(N-Boc-amino)-N'-benzylbutyramide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:456527-46-1 SDS

456527-46-1Relevant articles and documents

Characterization of Protease-Activated Receptor (PAR) ligands: Parmodulins are reversible allosteric inhibitors of PAR1-driven calcium mobilization in endothelial cells

Gandhi, Disha M.,Majewski, Mark W.,Rosas, Ricardo,Kentala, Kaitlin,Foster, Trevor J.,Greve, Eric,Dockendorff, Chris

, p. 2514 - 2529 (2018/04/30)

Several classes of ligands for Protease-Activated Receptors (PARs) have shown impressive anti-inflammatory and cytoprotective activities, including PAR2 antagonists and the PAR1-targeting parmodulins. In order to support medicinal chemistry studies with hundreds of compounds and to perform detailed mode-of-action studies, it became important to develop a reliable PAR assay that is operational with endothelial cells, which mediate the cytoprotective effects of interest. We report a detailed protocol for an intracellular calcium mobilization assay with adherent endothelial cells in multiwell plates that was used to study a number of known and new PAR1 and PAR2 ligands, including an alkynylated version of the PAR1 antagonist RWJ-58259 that is suitable for the preparation of tagged or conjugate compounds. Using the cell line EA.hy926, it was necessary to perform media exchanges with automated liquid handling equipment in order to obtain optimal and reproducible antagonist concentration-response curves. The assay is also suitable for study of PAR2 ligands; a peptide antagonist reported by Fairlie was synthesized and found to inhibit PAR2 in a manner consistent with reports using epithelial cells. The assay was used to confirm that vorapaxar acts as an irreversible antagonist of PAR1 in endothelium, and parmodulin 2 (ML161) and the related parmodulin RR-90 were found to inhibit PAR1 reversibly, in a manner consistent with negative allosteric modulation.

SOMATOSTATIN RECEPTOR 1 AND/OR 4 SELECTIVE AGONISTS AND ANTAGONISTS

-

Page/Page column 33, (2008/06/13)

The invention relates to (hetero)arylsulfonylamino based peptidomimetics of formula (I), wherein R1, R2, R3, A, B, D, Q, k and n are defined as disclosed, or a pharmaceutically acceptable salt or ester thereof. Compounds of formula (I) possess high affinity and selectivity for the somatostatin receptor subtypes SSTR1 and/or SSTR4 and can be used for the treatment or diagnosis of diseases or conditions wherein an interaction with SSTR1 and/or SSTR4 is indicated to be useful.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 456527-46-1